Temperature Controlled Packaging for Pharmaceutical Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Product (Insulated Shippers, Insulated Containers, Refrigerants); By Type (Active Systems, Passive Systems); By Temperature Range (Less than 10°C, 10°C to 20°C, More than 20°C); By Usability (Single, Reuse); By Application (Vaccine, Temperature Sensitive Pharmaceutical Drugs, Regenerative Medicine, Clinical Trial, Biopharma); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Global Temperature Controlled Packaging for Pharmaceutical Market Size Expanding to Cross USD 21 Billion by 2028
Global temperature controlled packaging for pharmaceutical market is flourishing due to rising demand for more advanced temperature controlled packaging techniques owing to the need for efficient temperature control of sensitive pharmaceutical products.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, forecasts the size of global temperature controlled packaging for pharmaceutical market to grow at an impressive CAGR of 10.6% between 2022 and 2028. The market size is expected to reach a value of USD 21.08 billion by 2028. Maintaining blood or vaccines requires temperature-controlled solutions. Pharmaceutical companies use cold chain solutions in this context to meet rising patient demand and the emergence of lifestyle diseases. The packaging options are made to keep desired temperature throughout the supply chain. Strict regulations that aim to improve pharmaceutical product distribution methods drive the market growth. Programs for improving packaging processes through research and development could aid the expansion of global temperature controlled packaging for pharmaceutical market size. Drugs and vaccines that must maintain specific electromechanical or electronic temperatures are shipped along with supporting logs that show how they were stored properly. The creation of novel medications and treatments may increase the need for cold-chain logistics.
Global Temperature Controlled Packaging for Pharmaceutical Market – Overview
Product protection, identification, information, and containment are all provided by temperature-controlled packaging techniques during storage, transportation, and up until the product is consumed. The demand for more sophisticated temperature controlled packaging techniques has increased because of the increased need for effective temperature control of delicate pharmaceutical products. Medicines that are delivered, such as insulin or cancer treatments, need to be kept at a constant temperature to keep them stable. These medications can be easily transported to specific locations in temperature-controlled packaging, preventing any negative external effects.
The development of temperature-controlled packaging containers considers sustainability. They are being developed to reduce risks associated with delivering subpar products and to adhere to quality standards by limiting carbon dioxide emissions. Digital technologies are being incorporated by logistics companies to track and monitor their products. For instance, Softbox and Pfizer collaborated on the supply and distribution of COVID-19 vaccines using a reusable ultra-low temperature insulated shipper.
Global Temperature Controlled Packaging for Pharmaceutical Market – Technology Advancements
Pharmaceutical companies concentrate more on developing treatments and medications for rare diseases, which is expected to spur the demand for temperature-controlled packaging solutions. The development of vaccines for rare diseases, including blood diseases, is generating profits for major players in the pharmaceutical industry. Increasing public support, expanding government programs, and encouraging businesses to create orphan drugs for the world's rare diseases. Additionally, a rise in newly developing markets and new strategic alliances will act as market catalysts and expand beneficial opportunities for the market's growth rate. Global temperature controlled packaging for pharmaceutical market has segments, such as Insulated Shippers, Insulated Containers, and Refrigerants by products; Active Systems and Passive Systems based on type; Less than 10°C, 10°C to 20°C, and More than 20°C by temperature range; Single and Reuse based on usability; Vaccine, Temperature Sensitive Pharmaceutical Drugs, Regenerative Medicine, Clinical Trial, and Biopharma based on application. Temperature sensitive pharmaceuticals segment is projected to dominate global temperature controlled packaging for pharmaceutical market, accounting for most of the market share.
Manufacturers are producing environmentally friendly and reusable packaging. In the transition to environmentally friendly technologies and the use of renewable plant-based materials, several manufacturing players are developing innovative products. For instance, in October 2019, GWP Group, a specialist in eco-friendly packaging and materials handling, launched a new returnable packaging system for corrugated boxes. In September 2019, CBS Packaging set up a new state-of-the-art 2.5m BHS Corrugator, at a fully integrated plant in Birmingham.
Impact of COVID-19 on Global Temperature Controlled Packaging for Pharmaceutical Market
For manufacturers of temperature controlled packaging solutions in the pharmaceutical industry, the COVID-19 pandemic created a lucrative opportunity. Guidelines established by health organizations for the preservation of vaccines and drugs led to the development of containers and shippers capable of preserving the integrity of the vaccine despite the container being exposed to ambient temperatures. Dry ice has been used to maintain the thermal temperature of delicate vaccines.
Competitive Landscape
Prominent players in global temperature controlled packaging for pharmaceutical market include Softbox Systems, FedEx Corporation, Sofrigam SA, Envirotainer AB, DGP Intelsius GMBH, Sonoco Products Company, Mondi Group, Pelican Biothermal, Cold Chain Technologies, Snyder Industries, Americk Packaging Group, H.B. Fuller Company, Va-Q-Tec AG, Inmark, LLC, United Parcel Service, Inc., and AmerisourceBergen Corporation. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in global temperature controlled packaging for pharmaceutical market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Temperature Controlled Packaging for Pharmaceutical Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Temperature Controlled Packaging for Pharmaceutical Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Type Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Global Temperature Controlled Packaging for Pharmaceutical Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Expanding pharmaceutical industry
- 3.2.1.2. Adoption of smarter cold chain technology
- 3.2.1.3. Growing concerns with safe pharmaceutical product transportation
- 3.2.2. Restraints
- 3.2.2.1. Strict guidelines for the shipment temperature-sensitive products
- 3.2.3. Opportunity
- 3.2.3.1. Increasing number of illnesses
- 3.2.3.2. Digitization of the TCP market will assist businesses in reducing operating costs and human checks
- 3.2.3.3. Advanced tracking technology and high-insulation-based packaging solutions
- 3.2.4. Challenges
- 3.2.4.1. High price of modern temperature-controlled packaging
- 3.2.4.2. Customs procedures and inadequate infrastructure for shipments requiring refrigeration in developing economies
- 3.3. Technological Advancement/Recent Development
- 3.4. Regulatory Framework
- 3.5. Porter’s Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
- 4. Global Temperature Controlled Packaging for Pharmaceutical Market Overview
- 4.1. Market Size & Forecast by Value, 2018-2028
- 4.1.1. By Value (USD Billion)
- 4.2. Market Share & Forecast
- 4.2.1. By Product
- 4.2.1.1. Insulated Shippers
- 4.2.1.2. Insulated Containers
- 4.2.1.3. Refrigerants
- 4.2.2. By Type
- 4.2.2.1. Active Systems
- 4.2.2.2. Passive Systems
- 4.2.3. By Temperature Range
- 4.2.3.1. Less than 10°C
- 4.2.3.2. 10°C to 20°C
- 4.2.3.3. More than 20°C
- 4.2.4. By Usability
- 4.2.4.1. Single
- 4.2.4.2. Reuse
- 4.2.5. By Application
- 4.2.5.1. Vaccine
- 4.2.5.2. Temperature Sensitive Pharmaceutical Drugs
- 4.2.5.3. Regenerative Medicine
- 4.2.5.4. Clinical Trial
- 4.2.5.5. Biopharma
- 4.2.6. By Region
- 4.2.6.1. North America
- 4.2.6.2. Europe
- 4.2.6.3. Asia Pacific
- 4.2.6.4. Latin America
- 4.2.6.5. Middle East and Africa
- 5. North America Temperature Controlled Packaging for Pharmaceutical Market
- 5.1.1. Market Size & Forecast by Value, 2018-2028
- 5.1.2. By Value (USD Billion)
- 5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Type
- 5.2.3. By Temperature Range
- 5.2.4. By Usability
- 5.2.5. By Application
- 5.2.6. By Country
- 5.2.6.1. United States
- 5.2.6.1.1. By Product
- 5.2.6.1.2. By Type
- 5.2.6.1.3. By Temperature Range
- 5.2.6.1.4. By Usability
- 5.2.6.1.5. By Application
- 5.2.6.2. Canada
- 5.2.6.2.1. By Product
- 5.2.6.2.2. By Type
- 5.2.6.2.3. By Temperature Range
- 5.2.6.2.4. By Usability
- 5.2.6.2.5. By Application
- 6. Europe Temperature Controlled Packaging for Pharmaceutical Market
- 6.1. Market Size & Forecast by Value, 2018-2028
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Type
- 6.2.3. By Temperature Range
- 6.2.4. By Usability
- 6.2.5. By Application
- 6.2.6. By Country
- 6.2.6.1. Germany
- 6.2.6.1.1. By Product
- 6.2.6.1.2. By Type
- 6.2.6.1.3. By Temperature Range
- 6.2.6.1.4. By Usability
- 6.2.6.1.5. By Application
- 6.2.6.2. United Kingdom
- 6.2.6.2.1. By Product
- 6.2.6.2.2. By Type
- 6.2.6.2.3. By Temperature Range
- 6.2.6.2.4. By Usability
- 6.2.6.2.5. By Application
- 6.2.6.3. Italy
- 6.2.6.3.1. By Product
- 6.2.6.3.2. By Type
- 6.2.6.3.3. By Temperature Range
- 6.2.6.3.4. By Usability
- 6.2.6.3.5. By Application
- 6.2.6.4. France
- 6.2.6.4.1. By Product
- 6.2.6.4.2. By Type
- 6.2.6.4.3. By Temperature Range
- 6.2.6.4.4. By Usability
- 6.2.6.4.5. By Application
- 6.2.6.5. Spain
- 6.2.6.5.1. By Product
- 6.2.6.5.2. By Type
- 6.2.6.5.3. By Temperature Range
- 6.2.6.5.4. By Usability
- 6.2.6.5.5. By Application
- 6.2.6.6. The Netherlands
- 6.2.6.6.1. By Product
- 6.2.6.6.2. By Type
- 6.2.6.6.3. By Temperature Range
- 6.2.6.6.4. By Usability
- 6.2.6.6.5. By Application
- 6.2.6.7. Belgium
- 6.2.6.7.1. By Product
- 6.2.6.7.2. By Type
- 6.2.6.7.3. By Temperature Range
- 6.2.6.7.4. By Usability
- 6.2.6.7.5. By Application
- 6.2.6.8. NORDIC Countries
- 6.2.6.8.1. By Product
- 6.2.6.8.2. By Type
- 6.2.6.8.3. By Temperature Range
- 6.2.6.8.4. By Usability
- 6.2.6.8.5. By Application
- 6.2.6.9. Rest of Europe
- 6.2.6.9.1. By Product
- 6.2.6.9.2. By Type
- 6.2.6.9.3. By Temperature Range
- 6.2.6.9.4. By Usability
- 6.2.6.9.5. By Application
- 7. Asia Pacific Temperature Controlled Packaging for Pharmaceutical Market
- 7.1. Market Size & Forecast by Value, 2018-2028
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Type
- 7.2.3. By Temperature Range
- 7.2.4. By Usability
- 7.2.5. By Application
- 7.2.6. By Country
- 7.2.6.1. China
- 7.2.6.1.1. By Product
- 7.2.6.1.2. By Type
- 7.2.6.1.3. By Temperature Range
- 7.2.6.1.4. By Usability
- 7.2.6.1.5. By Application
- 7.2.6.2. India
- 7.2.6.2.1. By Product
- 7.2.6.2.2. By Type
- 7.2.6.2.3. By Temperature Range
- 7.2.6.2.4. By Usability
- 7.2.6.2.5. By Application
- 7.2.6.3. Japan
- 7.2.6.3.1. By Product
- 7.2.6.3.2. By Type
- 7.2.6.3.3. By Temperature Range
- 7.2.6.3.4. By Usability
- 7.2.6.3.5. By Application
- 7.2.6.4. South Korea
- 7.2.6.4.1. By Product
- 7.2.6.4.2. By Type
- 7.2.6.4.3. By Temperature Range
- 7.2.6.4.4. By Usability
- 7.2.6.4.5. By Application
- 7.2.6.5. Australia & New Zealand
- 7.2.6.5.1. By Product
- 7.2.6.5.2. By Type
- 7.2.6.5.3. By Temperature Range
- 7.2.6.5.4. By Usability
- 7.2.6.5.5. By Application
- 7.2.6.6. Indonesia
- 7.2.6.6.1. By Product
- 7.2.6.6.2. By Type
- 7.2.6.6.3. By Temperature Range
- 7.2.6.6.4. By Usability
- 7.2.6.6.5. By Application
- 7.2.6.7. Malaysia
- 7.2.6.7.1. By Product
- 7.2.6.7.2. By Type
- 7.2.6.7.3. By Temperature Range
- 7.2.6.7.4. By Usability
- 7.2.6.7.5. By Application
- 7.2.6.8. Singapore
- 7.2.6.8.1. By Product
- 7.2.6.8.2. By Type
- 7.2.6.8.3. By Temperature Range
- 7.2.6.8.4. By Usability
- 7.2.6.8.5. By Application
- 7.2.6.9. Philippines
- 7.2.6.9.1. By Product
- 7.2.6.9.2. By Type
- 7.2.6.9.3. By Temperature Range
- 7.2.6.9.4. By Usability
- 7.2.6.9.5. By Application
- 7.2.6.10. Vietnam
- 7.2.6.10.1. By Product
- 7.2.6.10.2. By Type
- 7.2.6.10.3. By Temperature Range
- 7.2.6.10.4. By Usability
- 7.2.6.10.5. By Application
- 7.2.6.11. Rest of Asia Pacific
- 7.2.6.11.1. By Product
- 7.2.6.11.2. By Type
- 7.2.6.11.3. By Temperature Range
- 7.2.6.11.4. By Usability
- 7.2.6.11.5. By Application
- 8. Latin America Temperature Controlled Packaging for Pharmaceutical Market
- 8.1. Market Size & Forecast by Value, 2018-2028
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By Temperature Range
- 8.2.4. By Usability
- 8.2.5. By Application
- 8.2.6. By Country
- 8.2.6.1. Brazil
- 8.2.6.1.1. By Product
- 8.2.6.1.2. By Type
- 8.2.6.1.3. By Temperature Range
- 8.2.6.1.4. By Usability
- 8.2.6.1.5. By Application
- 8.2.6.2. Mexico
- 8.2.6.2.1. By Product
- 8.2.6.2.2. By Type
- 8.2.6.2.3. By Temperature Range
- 8.2.6.2.4. By Usability
- 8.2.6.2.5. By Application
- 8.2.6.3. Argentina
- 8.2.6.3.1. By Product
- 8.2.6.3.2. By Type
- 8.2.6.3.3. By Temperature Range
- 8.2.6.3.4. By Usability
- 8.2.6.3.5. By Application
- 8.2.6.4. Peru
- 8.2.6.4.1. By Product
- 8.2.6.4.2. By Type
- 8.2.6.4.3. By Temperature Range
- 8.2.6.4.4. By Usability
- 8.2.6.4.5. By Application
- 8.2.6.5. Colombia
- 8.2.6.5.1. By Product
- 8.2.6.5.2. By Type
- 8.2.6.5.3. By Temperature Range
- 8.2.6.5.4. By Usability
- 8.2.6.5.5. By Application
- 8.2.6.6. Rest of Latin America
- 8.2.6.6.1. By Product
- 8.2.6.6.2. By Type
- 8.2.6.6.3. By Temperature Range
- 8.2.6.6.4. By Usability
- 8.2.6.6.5. BY Application
- 9. Middle East & Africa Temperature Controlled Packaging for Pharmaceutical Market
- 9.1. Market Size & Forecast by Value, 2018-2028
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By Temperature Range
- 9.2.4. By Usability
- 9.2.5. By Application
- 9.2.6. By Country
- 9.2.6.1. Saudi Arabia
- 9.2.6.1.1. By Product
- 9.2.6.1.2. By Type
- 9.2.6.1.3. By Temperature Range
- 9.2.6.1.4. By Usability
- 9.2.6.1.5. By Application
- 9.2.6.2. UAE
- 9.2.6.2.1. By Product
- 9.2.6.2.2. By Type
- 9.2.6.2.3. By Temperature Range
- 9.2.6.2.4. By Usability
- 9.2.6.2.5. By Application
- 9.2.6.3. Qatar
- 9.2.6.3.1. By Product
- 9.2.6.3.2. By Type
- 9.2.6.3.3. By Temperature Range
- 9.2.6.3.4. By Usability
- 9.2.6.3.5. By Application
- 9.2.6.4. Kuwait
- 9.2.6.4.1. By Product
- 9.2.6.4.2. By Type
- 9.2.6.4.3. By Temperature Range
- 9.2.6.4.4. By Usability
- 9.2.6.4.5. By Application
- 9.2.6.5. Iran
- 9.2.6.5.1. By Product
- 9.2.6.5.2. By Type
- 9.2.6.5.3. By Temperature Range
- 9.2.6.5.4. By Usability
- 9.2.6.5.5. By Application
- 9.2.6.6. South Africa
- 9.2.6.6.1. By Product
- 9.2.6.6.2. By Type
- 9.2.6.6.3. By Temperature Range
- 9.2.6.6.4. By Usability
- 9.2.6.6.5. By Application
- 9.2.6.7. Nigeria
- 9.2.6.7.1. By Product
- 9.2.6.7.2. By Type
- 9.2.6.7.3. By Temperature Range
- 9.2.6.7.4. By Usability
- 9.2.6.7.5. By Application
- 9.2.6.8. Kenya
- 9.2.6.8.1. By Product
- 9.2.6.8.2. By Type
- 9.2.6.8.3. By Temperature Range
- 9.2.6.8.4. By Usability
- 9.2.6.8.5. By Application
- 9.2.6.9. Egypt
- 9.2.6.9.1. By Product
- 9.2.6.9.2. By Type
- 9.2.6.9.3. By Temperature Range
- 9.2.6.9.4. By Usability
- 9.2.6.9.5. By Application
- 9.2.6.10. Morocco
- 9.2.6.10.1. By Product
- 9.2.6.10.2. By Type
- 9.2.6.10.3. By Temperature Range
- 9.2.6.10.4. By Usability
- 9.2.6.10.5. By Application
- 9.2.6.11. Algeria
- 9.2.6.11.1. By Product
- 9.2.6.11.2. By Type
- 9.2.6.11.3. By Temperature Range
- 9.2.6.11.4. By Usability
- 9.2.6.11.5. By Application
- 9.2.6.12. Rest of Middle East & Africa
- 9.2.6.12.1. By Product
- 9.2.6.12.2. By Type
- 9.2.6.12.3. By Temperature Range
- 9.2.6.12.4. By Usability
- 9.2.6.12.5. By Application
- 10. Competitive Landscape
- 10.1. List of Key Players and Their Offerings
- 10.2. Global Temperature Controlled Packaging for Pharmaceutical Company Market Share Analysis, 2021
- 10.3. Competitive Benchmarking, By Operating Parameters
- 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)
- 11. Impact of Covid-19 on Global Temperature Controlled Packaging for Pharmaceutical Market
- 12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
- 12.1. Softbox Systems
- 12.2. FedEx Corporation
- 12.3. Sofrigam SA
- 12.4. Envirotainer AB
- 12.5. DGP Intelsius GMBH
- 12.6. Sonoco Products Company
- 12.7. Mondi Group
- 12.8. Pelican Biothermal
- 12.9. Cold Chain Technologies
- 12.10. Snyder Industries
- 12.11. Americk Packaging Group
- 12.12. H.B. Fuller Company
- 12.13. Va-Q-Tec AG
- 12.14. Inmark, LLC
- 12.15. United Parcel Service, Inc.
- 12.16. AmerisourceBergen Corporation
- 12.17. Other Prominent Players
- 13. Key Strategic Recommendations
- 14. Research Methodology
- 14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
- 14.2. Quantitative Research
- 14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
- 14.4. Breakdown of Primary Research Respondents, By Region
- 14.5. Assumptions & Limitations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook